These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 466248)

  • 1. Long-term parenteral exposure to mercury in patients with hypogammaglobulinaemia.
    Haeney MR; Carter GF; Yeoman WB; Thompson RA
    Br Med J; 1979 Jul; 2(6181):12-4. PubMed ID: 466248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic reactions due to thiomersal.
    Tosti A; Melino M; Bardazzi F
    Contact Dermatitis; 1986 Sep; 15(3):187-8. PubMed ID: 2946540
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mercury in vaccines].
    Hessel L
    Bull Acad Natl Med; 2003; 187(8):1501-10. PubMed ID: 15146581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiomersal.
    Wilkinson DS
    Contact Dermatitis; 1979 Jan; 5(1):58-9. PubMed ID: 421465
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute mercury poisoning after polyvinyl alcohol preservative ingestion.
    Seidel J
    Pediatrics; 1980 Jul; 66(1):132-4. PubMed ID: 7402778
    [No Abstract]   [Full Text] [Related]  

  • 6. Contact dermatitis from merthiolate.
    Melino M; Antonelli C; Barone M
    Contact Dermatitis; 1986 Feb; 14(2):125. PubMed ID: 3709153
    [No Abstract]   [Full Text] [Related]  

  • 7. Mercury concentrations and metabolism in infants receiving vaccines containing thiomersal: a descriptive study.
    Pichichero ME; Cernichiari E; Lopreiato J; Treanor J
    Lancet; 2002 Nov; 360(9347):1737-41. PubMed ID: 12480426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evidence for the safety of thiomersal in newborn and infant vaccines.
    Clements CJ
    Vaccine; 2004 May; 22(15-16):1854-61. PubMed ID: 15121295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiomersal as a vaccine preservative.
    Wkly Epidemiol Rec; 2000 Jan; 75(2):12-6. PubMed ID: 10697462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When science is not enough - a risk/benefit profile of thiomersal-containing vaccines.
    Clements CJ; McIntyre PB
    Expert Opin Drug Saf; 2006 Jan; 5(1):17-29. PubMed ID: 16370953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiomersal in vaccines: is removal warranted?
    Clements CJ; Ball LK; Ball R; Pratt RD
    Drug Saf; 2001; 24(8):567-74. PubMed ID: 11480489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Source and clinical significance of allergy for thiomersal, an organic mercury compound].
    van 't Veen AJ; van Joost T
    Ned Tijdschr Geneeskd; 1996 Feb; 140(6):297-300. PubMed ID: 8720702
    [No Abstract]   [Full Text] [Related]  

  • 13. Mercury in infants given vaccines containing thiomersal.
    Colman E
    Lancet; 2003 Feb; 361(9358):698; author reply 699. PubMed ID: 12606188
    [No Abstract]   [Full Text] [Related]  

  • 14. A case-control study evaluating the relationship between thimerosal-containing haemophilus influenzae type b vaccine administration and the risk for a pervasive developmental disorder diagnosis in the United States.
    Geier DA; Kern JK; King PG; Sykes LK; Geier MR
    Biol Trace Elem Res; 2015 Feb; 163(1-2):28-38. PubMed ID: 25382662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The three modern faces of mercury.
    Clarkson TW
    Environ Health Perspect; 2002 Feb; 110 Suppl 1(Suppl 1):11-23. PubMed ID: 11834460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure to thimerosal in vaccines used in Canadian infant immunization programs, with respect to risk of neurodevelopmental disorders.
    Bigham M; Copes R; Srour L
    Can Commun Dis Rep; 2002 May; 28(9):69-80. PubMed ID: 12012653
    [No Abstract]   [Full Text] [Related]  

  • 17. Thiomersal in vaccines: balancing the risk of adverse effects with the risk of vaccine-preventable disease.
    Bigham M; Copes R
    Drug Saf; 2005; 28(2):89-101. PubMed ID: 15691220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elimination of thimerosal from vaccines set as goal.
    Miller JL
    Am J Health Syst Pharm; 1999 Aug; 56(16):1589, 1593. PubMed ID: 10459378
    [No Abstract]   [Full Text] [Related]  

  • 19. Thimerosal exposure in infants and developmental disorders: a prospective cohort study in the United kingdom does not support a causal association.
    Heron J; Golding J;
    Pediatrics; 2004 Sep; 114(3):577-83. PubMed ID: 15342824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total mercury content in canine hair before and after administration of vaccines containing thiomersal.
    Sedlackova L; Kral T; Sevcikova M; Kruzikova K; Svobodova Z
    Neuro Endocrinol Lett; 2013; 34 Suppl 2():90-4. PubMed ID: 24362099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.